Publicaciones en colaboración con investigadores/as de Instituto Aragonés de Ciencias de la Salud (13)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Corrigendum to “Dissecting the genetic heterogeneity of gastric cancer” (eBioMedicine (2023) 92, (S2352396423001810), (10.1016/j.ebiom.2023.104616))

    eBioMedicine

  3. Dissecting the genetic heterogeneity of gastric cancer

    eBioMedicine, Vol. 92

2022

  1. Calcitonin gene–related peptide in migraine: from pathophysiology to treatment

    Neurologia, Vol. 37, Núm. 5, pp. 390-402

  2. Effect of a Multicomponent mHealth Intervention on the Composition of Diet in a Population with Overweight and Obesity-Randomized Clinical Trial EVIDENT 3

    Nutrients, Vol. 14, Núm. 2

  3. Long-term Effectiveness of a Smartphone App Combined With a Smart Band on Weight Loss, Physical Activity, and Caloric Intake in a Population With Overweight and Obesity (Evident 3 Study): Randomized Controlled Trial

    Journal of medical Internet research, Vol. 24, Núm. 2, pp. e30416

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2020

  1. Neuromuscular blockade management and postoperative outcomes in enhanced recovery colorectal surgery: Secondary analysis of POWER trial

    Minerva Anestesiologica, Vol. 87, Núm. 1, pp. 13-25

2019

  1. End-of-life care for patients hospitalised in internal medicine departments

    Revista Clinica Espanola, Vol. 219, Núm. 3, pp. 107-115

2018

  1. Personalized medicine into health national services: Barriers and potentialities

    Drug Metabolism and Personalized Therapy, Vol. 33, Núm. 4, pp. 159-163

2013

  1. Preventing the onset of major depression based on the level and profile of risk of primary care attendees: Protocol of a cluster randomised trial (the predictD-CCRT study)

    BMC Psychiatry, Vol. 13

2011

  1. Evaluation of Spanish Gaucher disease patients after a 6-month imiglucerase shortage

    Blood Cells, Molecules, and Diseases, Vol. 46, Núm. 1, pp. 115-118

2009

  1. Real-world clinical experience with long-term miglustat maintenance therapy in type 1 Gaucher disease: The ZAGAL project

    Haematologica, Vol. 94, Núm. 12, pp. 1771-1775